Adepeju (Peju) Oshisanya
Peju Oshisanya is Vice President of Clinical Programmes at BenevolentAI. She established the infrastructure required to run the Company’s clinical portfolio globally.
Peju is also a passionate advocate of diversity in data and inclusion in clinical trial research, and is determined to become a champion of change in the industry, working to raise awareness and ensure biomedical research is reflective of the global population.
Peju is an innovative operational strategy expert with over 20 years of wide-ranging experience relating to leading strategic programmes, and planning and managing clinical trials with responsibility for global clinical programmes. She has extensive experience in transitioning early-stage assets to clinical development. Before joining BenevolentAI, she held leadership positions in programme management responsible for key clinical programmes and assets within Eli Lilly, Sanofi Aventis, Pfizer and Takeda.